(4-((1H-imidazol-1-yl)methyl)-5-isopropyl-4,5-dihydrooxazol-2-yl)(biphenyl-4-yl)methanone

ID: ALA4876832

PubChem CID: 164626828

Max Phase: Preclinical

Molecular Formula: C22H23N3O

Molecular Weight: 345.45

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CC(C)C1OC(c2ccc(-c3ccccc3)cc2)=NC1Cn1ccnc1

Standard InChI:  InChI=1S/C22H23N3O/c1-16(2)21-20(14-25-13-12-23-15-25)24-22(26-21)19-10-8-18(9-11-19)17-6-4-3-5-7-17/h3-13,15-16,20-21H,14H2,1-2H3

Standard InChI Key:  DWLVVWOGJAJIKK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   16.0279  -16.2208    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.3157  -16.6339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4858  -17.4378    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.3032  -17.5232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6398  -16.7720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7180  -18.2385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3035  -18.9497    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4837  -19.0366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3131  -19.8440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.0285  -20.2586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6427  -19.7049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4431  -16.6024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9918  -17.2133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6980  -15.8217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5618  -16.2988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8474  -15.0612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1329  -15.4737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1329  -16.2988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8474  -16.7113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5618  -15.4737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4184  -15.0612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7040  -13.8237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9895  -14.2362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9895  -15.0612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7040  -15.4737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4184  -14.2362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  7  1  0
  5 12  1  0
 12 13  1  0
 12 14  1  0
  2 15  1  0
 19 15  2  0
 15 20  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 16 20  2  0
 17 21  1  0
 25 21  2  0
 21 26  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 22 26  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA4876832

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 345.45

Molecular Weight (Monoisotopic): 345.1841

AlogP: 4.42

#Rotatable Bonds: 5

Polar Surface Area: 39.41

Molecular Species: NEUTRAL

HBA: 4

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 6.77

CX LogP: 4.73

CX LogD: 4.66

Aromatic Rings: 3

Heavy Atoms: 26

QED Weighted: 0.69

Np Likeness Score: -0.24

References

1. Zhao L, Yin W, Sun Y, Sun N, Tian L, Zheng Y, Zhang C, Zhao S, Su X, Zhao D, Cheng M..  (2021)  Improving the metabolic stability of antifungal compounds based on a scaffold hopping strategy: Design, synthesis, and structure-activity relationship studies of dihydrooxazole derivatives.,  224  [PMID:34364163] [10.1016/j.ejmech.2021.113715]

Source

Source(1):

• Scientific Literature